Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00167
|
|||||
| Drug Name |
Taurine
|
|||||
| Synonyms |
.beta.-Aminoethylsulfonic acid; 1-Aminoethane-2-sulfonic acid; 107-35-7; 1EQV5MLY3D; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine; 2-aminoethane-1-sulfonic acid; 2-aminoethanesulfonic acid; AI3-18307; Aminoethanesulfonic acid; CCRIS 4721; CHEBI:15891; EINECS 203-483-8; Ethanesulfonic acid, 2-amino-; FEMA No. 3813; L-Taurine; NCI-C60606; NSC 32428; NSC32428; O-Due; Taurina [Spanish]; Taurine [INN]; Taurinum [Latin]; UNII-1EQV5MLY3D; aminoethylsulfonic acid; beta-Aminoethylsulfonic acid; taufon; tauphon
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Congestive heart failure [ICD11: BD10] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C2H7NO3S
|
|||||
| Canonical SMILES |
C(CS(=O)(=O)O)N
|
|||||
| InChI |
InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)
|
|||||
| InChIKey |
XOAAWQZATWQOTB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 107-35-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 125.15 | Topological Polar Surface Area | 88.8 | ||
| Heavy Atom Count | 7 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-4.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10503452
, 11111855
, 11113407
, 11407207
, 15146560
, 17389723
, 17405690
, 24278721
, 24439473
, 24888584
, 24888585
, 24900217
, 24900552
, 24901890
, 26751645
, 3136598
, 3544
, 37402452
, 46500351
, 46506189
, 4656526
, 47515475
, 48414494
, 48423589
, 48425250
, 49830281
, 49854645
, 50104337
, 50104338
, 53778240
, 53789289
, 56320736
, 56320737
, 57320751
, 57653091
, 608224
, 7847115
, 7890685
, 7980729
, 8027993
, 80818340
, 81059398
, 8138146
, 8145091
, 8150985
, 820951
, 821198
, 841390
, 855439
, 90924
|
|||||
| ChEBI ID |
CHEBI:15891
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | TAUT | Transporter Info | Sodium- and chloride-dependent taurine transporter | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT02344719) Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis | |||||
| 2 | Astrocytic -aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain. 2018 Feb;113:1-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.